Carbonyl Reductase 1 Offers a Novel Therapeutic Target to Enhance Leukemia Treatment by Arsenic Trioxide

Cancer Research - United States
doi 10.1158/0008-5472.can-12-1110
Full Text
Abstract

Available in full text

Date
Authors
Publisher

American Association for Cancer Research (AACR)

Related search

Impact of Arsenic Trioxide in the Treatment of Acute Promyelocytic Leukemia

Leukemia
Cancer ResearchOncologyAnesthesiologyPain MedicineHematology
2011English

Connexin43 Pseudogene in Breast Cancer Cells Offers a Novel Therapeutic Target

Molecular Cancer Therapeutics
Cancer ResearchOncology
2009English

STAT5b in LGL Leukemia &Ndash; A Novel Therapeutic Target?

Oncotarget
Oncology
2013English

Pseudotumor Cerebri After Treatment of Relapsed Acute Promyelocytic Leukemia With Arsenic Trioxide

Leukemia
Cancer ResearchOncologyAnesthesiologyPain MedicineHematology
2000English

Retinoic Acid and Arsenic Trioxide in the Treatment of Acute Promyelocytic Leukemia: Current Perspectives

OncoTargets and Therapy
OncologyPharmacology
2017English

‘Retinoic Acid and Arsenic Trioxide Sensitize Acute Promyelocytic Leukemia Cells to ER Stress’

Leukemia
Cancer ResearchOncologyAnesthesiologyPain MedicineHematology
2017English

Lymphocyte Activation Gene 3: A Novel Therapeutic Target in Chronic Lymphocytic Leukemia

Haematologica
Hematology
2017English

Arsenic Trioxide Enhances the Therapeutic Efficacy of Radiation Treatment of Oral Squamous Carcinoma While Protecting Bone

Molecular Cancer Therapeutics
Cancer ResearchOncology
2008English

Arsenic Trioxide (ATO) and MEK1 Inhibition Synergize to Induce Apoptosis in Acute Promyelocytic Leukemia Cells

Leukemia
Cancer ResearchOncologyAnesthesiologyPain MedicineHematology
2004English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2025 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy